These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11902576)

  • 1. FRA3B and other common fragile sites: the weakest links.
    Huebner K; Croce CM
    Nat Rev Cancer; 2001 Dec; 1(3):214-21. PubMed ID: 11902576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.
    Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW
    Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the FHIT/FRA3B locus in cancer.
    Huebner K; Garrison PN; Barnes LD; Croce CM
    Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.
    Ohta M; Inoue H; Cotticelli MG; Kastury K; Baffa R; Palazzo J; Siprashvili Z; Mori M; McCue P; Druck T; Croce CM; Huebner K
    Cell; 1996 Feb; 84(4):587-97. PubMed ID: 8598045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common fragile sites and cancer (review).
    Smith DI; Huang H; Wang L
    Int J Oncol; 1998 Jan; 12(1):187-96. PubMed ID: 9454904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
    Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P; Wilhelm M; Kovacs G
    Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.
    Matsuyama A; Shiraishi T; Trapasso F; Kuroki T; Alder H; Mori M; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14988-93. PubMed ID: 14630947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints.
    Paradee W; Wilke CM; Wang L; Shridhar R; Mullins CM; Hoge A; Glover TW; Smith DI
    Genomics; 1996 Jul; 35(1):87-93. PubMed ID: 8661108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome arm 8p and cancer: a fragile hypothesis.
    Birnbaum D; Adélaïde J; Popovici C; Charafe-Jauffret E; Mozziconacci MJ; Chaffanet M
    Lancet Oncol; 2003 Oct; 4(10):639-42. PubMed ID: 14554243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.
    Michael D; Beer DG; Wilke CW; Miller DE; Glover TW
    Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific late replication and fragility of the most active common fragile site, FRA3B.
    Wang L; Darling J; Zhang JS; Huang H; Liu W; Smith DI
    Hum Mol Genet; 1999 Mar; 8(3):431-7. PubMed ID: 9949202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT as tumor suppressor: mechanisms and therapeutic opportunities.
    Pekarsky Y; Palamarchuk A; Huebner K; Croce CM
    Cancer Biol Ther; 2002; 1(3):232-6. PubMed ID: 12432269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.
    Inoue H; Ishii H; Alder H; Snyder E; Druck T; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14584-9. PubMed ID: 9405656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.
    Popovici C; Basset C; Bertucci F; Orsetti B; Adélaide J; Mozziconacci MJ; Conte N; Murati A; Ginestier C; Charafe-Jauffret E; Ethier SP; Lafage-Pochitaloff M; Theillet C; Birnbaum D; Chaffanet M
    Genes Chromosomes Cancer; 2002 Nov; 35(3):204-18. PubMed ID: 12353263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the common fragile site FRA3B does not affect FHIT expression.
    Michael D; Rajewsky MF
    Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.